Al-Ola Abdallah, Associate Professor Of Medicine at University of Kansas Medical Center, shared on LinkedIn:
“From Cancer Network during the National ICE_T conference: Developing a Bridge to Optimize Cellular Therapy Use in Multiple Myeloma
More work is needed to expand access to novel CAR T-cell therapies and bispecific agents among community oncologists, according to Al-Ola A. Abdallah.”
More posts featuring Multiple Myeloma.